Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ADCT-701 by ADC Therapeutics for Neuroendocrine Carcinoma: Likelihood of Approval
ADCT-701 is under clinical development by ADC Therapeutics and currently in Phase I for Neuroendocrine Carcinoma. According to GlobalData, Phase...
Data Insights
ADCT-701 by ADC Therapeutics for Adrenocortical Carcinoma (Adrenal Cortex Cancer): Likelihood of Approval
ADCT-701 is under clinical development by ADC Therapeutics and currently in Phase I for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According...